维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="RAMSAY LE"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	African origins and chronic kidney disease susceptibility in the human immunodeficiency virus era显示文摘Chronic kidney disease(CKD) is a major public health problem worldwide with the estimated incidence growing by approximately 6% annually. There are striking ethnic differences in the prevalence of CKD such that, in the United States, African Americans have the highest prevalence of CKD, four times the incidence of end stage renal disease when compared to Americans of European ancestry suggestive of genetic predisposition. Diabetes mel itus, hypertension and human immunodeficiency virus(HIV) infection are the major causes of CKD. HIV-associated nephropathy(HIVAN) is an irreversible form of CKD with considerable morbidity and mortality and is present predominantly in people of African ancestry. The APOL1 G1 and G2 alleles were more strongly associated with the risk for CKD than the previously examined MYH9 E1 risk haplotype in individuals of African ancestry. A strong association was reported in HIVAN, suggesting that 50% of African Americans with two APOL1 risk alleles, if untreated, would develop HIVAN. However these two variants are not enough to cause disease. The prevailing belief is that modifying factors or second hits(including genetic hits) underlie the pathogenesis of kidney disease. This work reviews the history of genetic susceptibility of CKD and outlines current theories regarding the role for APOL1 in CKD in the HIV era.	Alex N Kasembeli Raquel Duarte Michèle Ramsay Saraladevi Naicker	2015	World Journal of Nephrology2015，4，2：	3
2	Combined inhibi- tion of neutral endopeptidase and angiotensin - converting enzyme by samptrilant in essential hypertension 显示文摘	Wallis E J Ramsay LE Hettiarachchi J	1998	Clin Pharmacol Ther1998，64，4：	1
3	Weight reduction in a blood pressure clinic显示文摘	Ramsay LE Ramsay MH Hetliarachchi J	1978	Br Med J1978，2，：	1
4	Influence of diuretics calcium antagonists and alpha-blockers on insulin sensitive and glucose tolerance in hypertensive patients显示文摘	Ramsay LE Yeo WW Jackson PR	1992	J Cardiovasc Pharmacol1992，20，：	1
5	First-line treatment for hypertension显示文摘	Jackson PR Ramsay LE	2002	Eur Heart J2002，23，3：	1
6	Might non - pharmacological treatment disadvantage patients with hypertension 显示文摘	Ramsay LE Haq IU Yeo WW	1995	J Hum Hypertens1995，9，8：	1
7	Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertensi on显示文摘	WALLIS EJ RAMSAY LE HETTIARACHCHI J	1998	Clin Pharmacol Ther1998，64，4：	1
8	British Hgpertension Society Guidelines for Hypertension Management 1999 显示文摘	Ramsay LE William B Johnson GD	1999	BMJ1999，319，14：	1
9	Drug intolerance due to nonspecific adverse effects related to psychiatric morbidity in hypertensive patients显示文摘	Davies SJ Jackson PR Ramsay LE	2003	Arch Intern Med2003，163，：	1
10	Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by samptrilant in essential hypertension显示文摘	Wallis EJ Ramsay LE Hettiarachchi J		0，，04：	1
11	Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials显示文摘	Sanmuganathan PS Ghahramani P Jackson PR Wallis EJ Ramsay LE	2001	Heart2001，85，3：	1
12	Non-pharmacological therapy of hypertension显示文摘	Ramsay LE	1994	Br Med Bull1994，50，：	1
13	Placebo controlled trial of atenolo and nifedipine and their combination显示文摘	Ramsay LE	1991	BMJ1991，，：	1
14	Might non-pharmacological treatment disadvantage patients with hypertension显示文摘	Ramsay LE Haq IU Yeo WW	1999	CMAJ1999，160，9：	1
15	The Sheffield table for primary prevention of coronary heart disease : corrected 显示文摘	Ramsay LE Haq IU Jackson PR	1996	Lan- cet1996，348，9036：	1
16	Non-phamacological therapy of hypertension显示文摘	Ramsay LE	1994	Br Med Bull1994，50，：	1
17	Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by samptrilant in essential hypertension显示文摘	Wallis EJ Ramsay LE Hettiarachchi J	1998	Clin Pharmacol Ther1998，64，4：	1
18	Persistent dry cough with enalapril:incidence depends on method used 显示文摘	Yeo WW Ramsay LE	1999	J Human Hypertens1999，4，：	1
19	Statins for primary prevention:at what coronary risk is safety assured显示文摘	Jackson PR Wallis EJ Haq IU Ramsay LE	2001	Br J Clin Pharmacol2001，52，4：	1
20	Is 'improvement' real with per- cutaneous transluminal angioplasty in the management of renovascular hypertension? 显示文摘	Brawn LA Ramsay LE	1987	Lancet1987，2，8571：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示